Jaguar Health Inc (JAGX)

[ShadowDiviner72]

What does this board think about the possibility of JAGX presenting ONTARGET results at AACR? ... Some reasons:
AACR is the number 1 cancer congress , it will only accept abstracts of clinical trials that where not published or presented yet. They want to be the first to present breaking new cancer research. To ensure this, they embargoe all clinical abstracts until the start of the congress. The companies who wants to present there, may not publish any results before the AACR congres. This would immediately explain why we are waiting sooo long for ONTARGET results.

Second, Crofelemer was allready presented at AACR in 2020, by Jaguar Health offcourse, but for CID in Dogs. So why would AACR not be interested to present Phase 3 clinical trial in humans.

!! Go to the website of AACR, you will see that the online publication of the program (and abstracts) is on March 5th. Next tuesday. Only after or on that data, companies that were accepted to present, may PR that they will present there.